Missing data refers to information that is not available for a particular observation or participant in a clinical study. This can occur when data is not collected, lost, or when participants drop out of a study before its completion.
Missing data can pose significant challenges in clinical research, potentially introducing bias and affecting the validity of study results. Researchers must carefully account for and address missing data using appropriate statistical methods to ensure the integrity of their analyses and conclusions.
Missing data is crucial in clinical research because it can significantly impact the validity and reliability of study results. Failing to properly address missing data can lead to biased estimates, reduced statistical power, and potentially incorrect conclusions about treatment efficacy or safety.
Understanding and managing missing data is essential for maintaining the integrity of clinical trials and ensuring regulatory compliance. Proper handling of missing data demonstrates the robustness of research methodologies and enhances the credibility of findings, which is critical for drug development and approval processes.
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
How Axcellant helped a diagnostic study overcome isotope supply, manufacturing, and logistics constraints In radiopharmaceutical development, we often say that…
Europe’s clinical trials market is entering a more practical phase in its approach to competitiveness. With the Clinical Trials Regulation…
Copyright @ 2026 Axcellant